dc.contributor.author | Acara, Ahmet Çağdaş | |
dc.contributor.author | Bolatkale, Mustafa | |
dc.contributor.author | Kızıloğlu, İlker | |
dc.contributor.author | İbişoğlu, Ersin | |
dc.contributor.author | Can, Çagdaş | |
dc.date.accessioned | 10.07.201910:49:13 | |
dc.date.accessioned | 2019-07-10T19:50:24Z | |
dc.date.available | 10.07.201910:49:13 | |
dc.date.available | 2019-07-10T19:50:24Z | |
dc.date.issued | 2018 | en_US |
dc.identifier.citation | Acara, A., Bolatkale, M., Kızıloğlu, İ., İbişoğlu, E. ve Can, Ç. (2018). A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin. American Journal of Emergency Medicine, 36(8), 1504-1505. https://dx.doi.org/10.1016/j.ajem.2017.12.032 | en_US |
dc.identifier.issn | 0735-6757 | |
dc.identifier.issn | 1532-8171 | |
dc.identifier.uri | https://dx.doi.org/10.1016/j.ajem.2017.12.032 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/1975 | |
dc.description | WOS: 000439103800039 | en_US |
dc.description | PubMed ID: 29274804 | en_US |
dc.description.abstract | Ischemic Heart Disease (IHD) is the leading cause of death world-wide, accounting for 12.7% of global mortality[1] . Acute Coronary Syn-drome (ACS) covers a wide spectrum of clinical conditions ranging fromunstable angina to Non-ST Elevation Myocardial Infarction (N-STEMI)and ST Elevation Myocardial Infarction (STEMI). New treatments andmanagement guidelines emerge for the care of patients with ACS; riskstratification is the cornerstone in the initial evaluation of these patients[2] . That inflammatory mediators play a role duringthe evolution of ACSis indicated by the widespread coronary inflammation found during un-stable angina pectoris (UAP), throughout theentire coronary artery bed,and in the extent that ACS outcome is related to a concurrent inflamma-toryresponse[3,4] . Circulatingasprosin,a protein hormone, responds tolow dietary glucose by triggering the release of liver glucose stores, andthe reduction of asprosin protects against the hyperinsulinism associat-ed with metabolic syndrome. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | W B Saunders Co-Elsevıer Inc | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Asprosin | en_US |
dc.subject | Biochemical Marker | en_US |
dc.subject | Angina Pectoris | en_US |
dc.title | A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin | en_US |
dc.type | letter | en_US |
dc.relation.ispartof | American Journal of Emergency Medicine | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Acil Tıp Ana Bilim Dalı | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı | en_US |
dc.identifier.volume | 36 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.startpage | 1504 | en_US |
dc.identifier.endpage | 1505 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1016/j.ajem.2017.12.032 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.identifier.scopusquality | Q1 | en_US |